Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
95.87
-1.19 (-1.23%)
Mar 20, 2026, 1:49 PM EDT - Market open
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $7.54 billion as of March 20, 2026. Its market cap has increased by 46.23% in one year.
Market Cap
7.54B
Enterprise Value
6.28B
1-Year Change
46.23%
Ranking
Category
Stock Price
$95.87
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $7.54B, an increase of 846.90%. That is a compound annual growth rate of 62.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 7.63B | -2.32% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 8.80B |
| Axsome Therapeutics | 8.08B |
| Praxis Precision Medicines | 8.04B |
| Bio-Techne | 7.95B |
| Arrowhead Pharmaceuticals | 7.94B |
| Vaxcyte | 7.81B |
| Cytokinetics | 7.66B |
| Halozyme Therapeutics | 7.51B |